propranolol has been researched along with Familial Turner Syndrome in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, A | 1 |
| Beasley, G | 1 |
| Martinez, H | 1 |
| Jesudas, R | 1 |
| Anton-Martin, P | 1 |
| Christakopoulos, G | 1 |
| Kramer, J | 1 |
| Levin, MD | 1 |
| Saitta, SC | 1 |
| Gripp, KW | 1 |
| Wenger, TL | 1 |
| Ganesh, J | 1 |
| Kalish, JM | 1 |
| Epstein, MR | 1 |
| Smith, R | 1 |
| Czosek, RJ | 1 |
| Ware, SM | 1 |
| Goldenberg, P | 1 |
| Myers, A | 1 |
| Chatfield, KC | 1 |
| Gillespie, MJ | 1 |
| Zackai, EH | 1 |
| Lin, AE | 1 |
| Takahashi, K | 1 |
| Kogaki, S | 1 |
| Kurotobi, S | 1 |
| Nasuno, S | 1 |
| Ohta, M | 1 |
| Okabe, H | 1 |
| Wada, K | 1 |
| Sakai, N | 1 |
| Taniike, M | 1 |
| Ozono, K | 1 |
| Ostman-Smith, I | 1 |
| Wettrell, G | 1 |
| Riesenfeld, T | 1 |
| Jackson, G | 1 |
| Anand, IS | 1 |
| Oram, S | 1 |
1 trial available for propranolol and Familial Turner Syndrome
| Article | Year |
|---|---|
A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Child; Cohort S | 1999 |
5 other studies available for propranolol and Familial Turner Syndrome
| Article | Year |
|---|---|
Selumetinib for Refractory Pulmonary and Gastrointestinal Bleeding in Noonan Syndrome.
Topics: Benzimidazoles; Dipyridamole; Gastrointestinal Hemorrhage; Humans; Interferon-alpha; Male; Mitogen-A | 2022 |
Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Topics: Amiodarone; Arrhythmias, Cardiac; Calcium; Cardiomyopathy, Hypertrophic; Costello Syndrome; Digoxin; | 2018 |
Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
Topics: Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; | 2019 |
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Chromosomes, Human, Pair 12; Drug Therapy, Comb | 2005 |
Asymmetric septal hypertrophy and propranolol treatment in a case of Ullrich-Noonan syndrome.
Topics: Aortic Valve Stenosis; Child, Preschool; Heart Septal Defects, Ventricular; Heart Septum; Humans; Ma | 1979 |